What Should I Know About Immunotherapy for Lung Cancer?
Immunotherapy represents a promising frontier in lung cancer treatment, leveraging the body’s immune system to target and destroy cancer cells. It is particularly effective for both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), utilizing drugs like Atezolizumab, Nivolumab, and Pembrolizumab. By blocking proteins such as PD-1 and PD-L1, these therapies enhance […]